TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Cell and Gene Therapy Manufacturing Services Market Research Report 2024(Status and Outlook)

Global Cell and Gene Therapy Manufacturing Services Market Research Report 2024(Status and Outlook)

  • Category:Life Sciences
  • Published on : 01 February 2024
  • Pages :170
  • Formats:
  • Report Code:SMR-7895168
OfferClick for best price

Best Price: $2560

Cell Gene Therapy Manufacturing Services Market Size, Share 2024


The Global Cell and Gene Therapy Manufacturing Services Market Size was estimated at USD 5193.18 million in 2023 and is projected to reach USD 8661.65 million by 2029, exhibiting a CAGR of 8.90% during the forecast period.

The USA market for Global Cell and Gene Therapy Manufacturing Services market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Cell and Gene Therapy Manufacturing Services market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Cell and Gene Therapy Manufacturing Services market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Report Overview:

Gene therapy aims to treat disorders by replacing or introducing genes into cells either inside the body (in vivo) or outside of the body (ex vivo).

This report provides a deep insight into the global Cell and Gene Therapy Manufacturing Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Manufacturing Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Manufacturing Services market in any manner.

Global Cell and Gene Therapy Manufacturing Services Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

  • Thermo Fisher Scientific
  • Merck KGaA
  • Charles River Laboratories
  • Lonza
  • Catalent
  • WuXi AppTec
  • Takara Bio Inc
  • Nikon Corporation
  • FUJIFILM Holdings Corporation
  • F. Hoffmann-La Roche
  • Oxford Biomedica Plc
  • Cell and Gene Therapy Catapult
  • The Discovery Labs LLC
  • RoslinCT
  • JRS PHARMA
  • FinVector
  • ABL
  • Resilience
  • BioCentriq
  • Porton Biopharma Limited
  • Andelyn Biosciences

Market Segmentation (by Type)

By Cell Therapy

  • Allogeneic
  • Autologous
  • Viral Vector

By Gene Therapy

  • Non-viral Vector
  • Oligonucleotides
  • Viral Vector
  • Virus Vector

Market Segmentation (by Application)

  • Oncology Diseases
  • Cardiovascular Diseases
  • Orthopedic Diseases
  • Ophthalmology Diseases
  • Infectious Diseases
  • Others

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Cell and Gene Therapy Manufacturing Services Market
  • Overview of the regional outlook of the Cell and Gene Therapy Manufacturing Services Market:

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Manufacturing Services Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

 

Report Attributes Report Details
Report Title Global Cell and Gene Therapy Manufacturing Services Market Research Report 2024(Status and Outlook)
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 170 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Manufacturing Services
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy Manufacturing Services Segment by Type
1.2.2 Cell and Gene Therapy Manufacturing Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cell and Gene Therapy Manufacturing Services Market Overview
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cell and Gene Therapy Manufacturing Services Market Competitive Landscape
3.1 Global Cell and Gene Therapy Manufacturing Services Sales by Manufacturers (2019-2024)
3.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell and Gene Therapy Manufacturing Services Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell and Gene Therapy Manufacturing Services Sales Sites, Area Served, Product Type
3.6 Cell and Gene Therapy Manufacturing Services Market Competitive Situation and Trends
3.6.1 Cell and Gene Therapy Manufacturing Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell and Gene Therapy Manufacturing Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.1 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell and Gene Therapy Manufacturing Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cell and Gene Therapy Manufacturing Services Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2019-2024)
6.3 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2019-2024)
6.4 Global Cell and Gene Therapy Manufacturing Services Price by Type (2019-2024)
7 Cell and Gene Therapy Manufacturing Services Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy Manufacturing Services Market Sales by Application (2019-2024)
7.3 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2019-2024)
7.4 Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2019-2024)
8 Cell and Gene Therapy Manufacturing Services Market Segmentation by Region
8.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
8.1.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
8.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region
8.2 North America
8.2.1 North America Cell and Gene Therapy Manufacturing Services Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell and Gene Therapy Manufacturing Services Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell and Gene Therapy Manufacturing Services Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Basic Information
9.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
9.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Merck KGaA
9.2.1 Merck KGaA Cell and Gene Therapy Manufacturing Services Basic Information
9.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
9.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Market Performance
9.2.4 Merck KGaA Business Overview
9.2.5 Merck KGaA Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.2.6 Merck KGaA Recent Developments
9.3 Charles River Laboratories
9.3.1 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Basic Information
9.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
9.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Market Performance
9.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.3.5 Charles River Laboratories Business Overview
9.3.6 Charles River Laboratories Recent Developments
9.4 Lonza
9.4.1 Lonza Cell and Gene Therapy Manufacturing Services Basic Information
9.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Overview
9.4.3 Lonza Cell and Gene Therapy Manufacturing Services Product Market Performance
9.4.4 Lonza Business Overview
9.4.5 Lonza Recent Developments
9.5 Catalent
9.5.1 Catalent Cell and Gene Therapy Manufacturing Services Basic Information
9.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Overview
9.5.3 Catalent Cell and Gene Therapy Manufacturing Services Product Market Performance
9.5.4 Catalent Business Overview
9.5.5 Catalent Recent Developments
9.6 WuXi AppTec
9.6.1 WuXi AppTec Cell and Gene Therapy Manufacturing Services Basic Information
9.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
9.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Market Performance
9.6.4 WuXi AppTec Business Overview
9.6.5 WuXi AppTec Recent Developments
9.7 Takara Bio Inc
9.7.1 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Basic Information
9.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
9.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Market Performance
9.7.4 Takara Bio Inc Business Overview
9.7.5 Takara Bio Inc Recent Developments
9.8 Nikon Corporation
9.8.1 Nikon Corporation Cell and Gene Therapy Manufacturing Services Basic Information
9.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
9.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
9.8.4 Nikon Corporation Business Overview
9.8.5 Nikon Corporation Recent Developments
9.9 FUJIFILM Holdings Corporation
9.9.1 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Basic Information
9.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
9.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
9.9.4 FUJIFILM Holdings Corporation Business Overview
9.9.5 FUJIFILM Holdings Corporation Recent Developments
9.10 F. Hoffmann-La Roche
9.10.1 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Basic Information
9.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
9.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Market Performance
9.10.4 F. Hoffmann-La Roche Business Overview
9.10.5 F. Hoffmann-La Roche Recent Developments
9.11 Oxford Biomedica Plc
9.11.1 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Basic Information
9.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
9.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Market Performance
9.11.4 Oxford Biomedica Plc Business Overview
9.11.5 Oxford Biomedica Plc Recent Developments
9.12 Cell and Gene Therapy Catapult
9.12.1 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Basic Information
9.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
9.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Market Performance
9.12.4 Cell and Gene Therapy Catapult Business Overview
9.12.5 Cell and Gene Therapy Catapult Recent Developments
9.13 The Discovery Labs LLC
9.13.1 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Basic Information
9.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
9.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Market Performance
9.13.4 The Discovery Labs LLC Business Overview
9.13.5 The Discovery Labs LLC Recent Developments
9.14 RoslinCT
9.14.1 RoslinCT Cell and Gene Therapy Manufacturing Services Basic Information
9.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
9.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Product Market Performance
9.14.4 RoslinCT Business Overview
9.14.5 RoslinCT Recent Developments
9.15 JRS PHARMA
9.15.1 JRS PHARMA Cell and Gene Therapy Manufacturing Services Basic Information
9.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
9.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Market Performance
9.15.4 JRS PHARMA Business Overview
9.15.5 JRS PHARMA Recent Developments
9.16 FinVector
9.16.1 FinVector Cell and Gene Therapy Manufacturing Services Basic Information
9.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Overview
9.16.3 FinVector Cell and Gene Therapy Manufacturing Services Product Market Performance
9.16.4 FinVector Business Overview
9.16.5 FinVector Recent Developments
9.17 ABL
9.17.1 ABL Cell and Gene Therapy Manufacturing Services Basic Information
9.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Overview
9.17.3 ABL Cell and Gene Therapy Manufacturing Services Product Market Performance
9.17.4 ABL Business Overview
9.17.5 ABL Recent Developments
9.18 Resilience
9.18.1 Resilience Cell and Gene Therapy Manufacturing Services Basic Information
9.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Overview
9.18.3 Resilience Cell and Gene Therapy Manufacturing Services Product Market Performance
9.18.4 Resilience Business Overview
9.18.5 Resilience Recent Developments
9.19 BioCentriq
9.19.1 BioCentriq Cell and Gene Therapy Manufacturing Services Basic Information
9.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
9.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Product Market Performance
9.19.4 BioCentriq Business Overview
9.19.5 BioCentriq Recent Developments
9.20 Porton Biopharma Limited
9.20.1 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Basic Information
9.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
9.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Market Performance
9.20.4 Porton Biopharma Limited Business Overview
9.20.5 Porton Biopharma Limited Recent Developments
9.21 Andelyn Biosciences
9.21.1 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Basic Information
9.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
9.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Market Performance
9.21.4 Andelyn Biosciences Business Overview
9.21.5 Andelyn Biosciences Recent Developments
9.22 Commercializing Living Therapies
9.22.1 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Basic Information
9.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
9.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Market Performance
9.22.4 Commercializing Living Therapies Business Overview
9.22.5 Commercializing Living Therapies Recent Developments
9.23 Vibalogics
9.23.1 Vibalogics Cell and Gene Therapy Manufacturing Services Basic Information
9.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
9.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Product Market Performance
9.23.4 Vibalogics Business Overview
9.23.5 Vibalogics Recent Developments
9.24 Anemocyte Srl
9.24.1 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Basic Information
9.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
9.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Market Performance
9.24.4 Anemocyte Srl Business Overview
9.24.5 Anemocyte Srl Recent Developments
9.25 ElevateBio
9.25.1 ElevateBio Cell and Gene Therapy Manufacturing Services Basic Information
9.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
9.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Product Market Performance
9.25.4 ElevateBio Business Overview
9.25.5 ElevateBio Recent Developments
10 Cell and Gene Therapy Manufacturing Services Market Forecast by Region
10.1 Global Cell and Gene Therapy Manufacturing Services Market Size Forecast
10.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country
10.2.3 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Forecast by Region
10.2.4 South America Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Manufacturing Services by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell and Gene Therapy Manufacturing Services by Type (2025-2030)
11.1.2 Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell and Gene Therapy Manufacturing Services by Type (2025-2030)
11.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Application (2025-2030)
11.2.1 Global Cell and Gene Therapy Manufacturing Services Sales (K Units) Forecast by Application
11.2.2 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Manufacturing Services Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2022)
Table 10. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell and Gene Therapy Manufacturing Services Sales Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy Manufacturing Services Product Type
Table 13. Global Cell and Gene Therapy Manufacturing Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell and Gene Therapy Manufacturing Services
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell and Gene Therapy Manufacturing Services Market Challenges
Table 22. Global Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 23. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 24. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2019-2024)
Table 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2019-2024)
Table 26. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell and Gene Therapy Manufacturing Services Market Size Share by Type (2019-2024)
Table 28. Global Cell and Gene Therapy Manufacturing Services Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application
Table 30. Global Cell and Gene Therapy Manufacturing Services Market Size by Application
Table 31. Global Cell and Gene Therapy Manufacturing Services Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2019-2024)
Table 33. Global Cell and Gene Therapy Manufacturing Services Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2019-2024)
Table 35. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell and Gene Therapy Manufacturing Services Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2019-2024)
Table 38. North America Cell and Gene Therapy Manufacturing Services Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell and Gene Therapy Manufacturing Services Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell and Gene Therapy Manufacturing Services Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Region (2019-2024) & (K Units)
Table 43. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Basic Information
Table 44. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
Table 45. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Thermo Fisher Scientific Business Overview
Table 47. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services SWOT Analysis
Table 48. Thermo Fisher Scientific Recent Developments
Table 49. Merck KGaA Cell and Gene Therapy Manufacturing Services Basic Information
Table 50. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
Table 51. Merck KGaA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck KGaA Business Overview
Table 53. Merck KGaA Cell and Gene Therapy Manufacturing Services SWOT Analysis
Table 54. Merck KGaA Recent Developments
Table 55. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Basic Information
Table 56. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
Table 57. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Charles River Laboratories Cell and Gene Therapy Manufacturing Services SWOT Analysis
Table 59. Charles River Laboratories Business Overview
Table 60. Charles River Laboratories Recent Developments
Table 61. Lonza Cell and Gene Therapy Manufacturing Services Basic Information
Table 62. Lonza Cell and Gene Therapy Manufacturing Services Product Overview
Table 63. Lonza Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Lonza Business Overview
Table 65. Lonza Recent Developments
Table 66. Catalent Cell and Gene Therapy Manufacturing Services Basic Information
Table 67. Catalent Cell and Gene Therapy Manufacturing Services Product Overview
Table 68. Catalent Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Catalent Business Overview
Table 70. Catalent Recent Developments
Table 71. WuXi AppTec Cell and Gene Therapy Manufacturing Services Basic Information
Table 72. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
Table 73. WuXi AppTec Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. WuXi AppTec Business Overview
Table 75. WuXi AppTec Recent Developments
Table 76. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Basic Information
Table 77. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
Table 78. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Takara Bio Inc Business Overview
Table 80. Takara Bio Inc Recent Developments
Table 81. Nikon Corporation Cell and Gene Therapy Manufacturing Services Basic Information
Table 82. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 83. Nikon Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Nikon Corporation Business Overview
Table 85. Nikon Corporation Recent Developments
Table 86. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Basic Information
Table 87. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 88. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. FUJIFILM Holdings Corporation Business Overview
Table 90. FUJIFILM Holdings Corporation Recent Developments
Table 91. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Basic Information
Table 92. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
Table 93. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. F. Hoffmann-La Roche Business Overview
Table 95. F. Hoffmann-La Roche Recent Developments
Table 96. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Basic Information
Table 97. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
Table 98. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Oxford Biomedica Plc Business Overview
Table 100. Oxford Biomedica Plc Recent Developments
Table 101. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Basic Information
Table 102. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
Table 103. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Cell and Gene Therapy Catapult Business Overview
Table 105. Cell and Gene Therapy Catapult Recent Developments
Table 106. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Basic Information
Table 107. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
Table 108. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. The Discovery Labs LLC Business Overview
Table 110. The Discovery Labs LLC Recent Developments
Table 111. RoslinCT Cell and Gene Therapy Manufacturing Services Basic Information
Table 112. RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
Table 113. RoslinCT Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. RoslinCT Business Overview
Table 115. RoslinCT Recent Developments
Table 116. JRS PHARMA Cell and Gene Therapy Manufacturing Services Basic Information
Table 117. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
Table 118. JRS PHARMA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. JRS PHARMA Business Overview
Table 120. JRS PHARMA Recent Developments
Table 121. FinVector Cell and Gene Therapy Manufacturing Services Basic Information
Table 122. FinVector Cell and Gene Therapy Manufacturing Services Product Overview
Table 123. FinVector Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. FinVector Business Overview
Table 125. FinVector Recent Developments
Table 126. ABL Cell and Gene Therapy Manufacturing Services Basic Information
Table 127. ABL Cell and Gene Therapy Manufacturing Services Product Overview
Table 128. ABL Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. ABL Business Overview
Table 130. ABL Recent Developments
Table 131. Resilience Cell and Gene Therapy Manufacturing Services Basic Information
Table 132. Resilience Cell and Gene Therapy Manufacturing Services Product Overview
Table 133. Resilience Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Resilience Business Overview
Table 135. Resilience Recent Developments
Table 136. BioCentriq Cell and Gene Therapy Manufacturing Services Basic Information
Table 137. BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
Table 138. BioCentriq Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. BioCentriq Business Overview
Table 140. BioCentriq Recent Developments
Table 141. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Basic Information
Table 142. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
Table 143. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Porton Biopharma Limited Business Overview
Table 145. Porton Biopharma Limited Recent Developments
Table 146. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Basic Information
Table 147. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
Table 148. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Andelyn Biosciences Business Overview
Table 150. Andelyn Biosciences Recent Developments
Table 151. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Basic Information
Table 152. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
Table 153. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Commercializing Living Therapies Business Overview
Table 155. Commercializing Living Therapies Recent Developments
Table 156. Vibalogics Cell and Gene Therapy Manufacturing Services Basic Information
Table 157. Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
Table 158. Vibalogics Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. Vibalogics Business Overview
Table 160. Vibalogics Recent Developments
Table 161. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Basic Information
Table 162. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
Table 163. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 164. Anemocyte Srl Business Overview
Table 165. Anemocyte Srl Recent Developments
Table 166. ElevateBio Cell and Gene Therapy Manufacturing Services Basic Information
Table 167. ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
Table 168. ElevateBio Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 169. ElevateBio Business Overview
Table 170. ElevateBio Recent Developments
Table 171. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Region (2025-2030) & (K Units)
Table 172. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Region (2025-2030) & (M USD)
Table 173. North America Cell and Gene Therapy Manufacturing Services Sales Forecast by Country (2025-2030) & (K Units)
Table 174. North America Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 175. Europe Cell and Gene Therapy Manufacturing Services Sales Forecast by Country (2025-2030) & (K Units)
Table 176. Europe Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 177. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Forecast by Region (2025-2030) & (K Units)
Table 178. Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Forecast by Region (2025-2030) & (M USD)
Table 179. South America Cell and Gene Therapy Manufacturing Services Sales Forecast by Country (2025-2030) & (K Units)
Table 180. South America Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 181. Middle East and Africa Cell and Gene Therapy Manufacturing Services Consumption Forecast by Country (2025-2030) & (Units)
Table 182. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country (2025-2030) & (M USD)
Table 183. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Type (2025-2030) & (K Units)
Table 184. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2025-2030) & (M USD)
Table 185. Global Cell and Gene Therapy Manufacturing Services Price Forecast by Type (2025-2030) & (USD/Unit)
Table 186. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) Forecast by Application (2025-2030)
Table 187. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Cell and Gene Therapy Manufacturing Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD), 2019-2030
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) (2019-2030)
Figure 6. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy Manufacturing Services Market Size by Country (M USD)
Figure 11. Cell and Gene Therapy Manufacturing Services Sales Share by Manufacturers in 2023
Figure 12. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers in 2023
Figure 13. Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell and Gene Therapy Manufacturing Services Market Share by Type
Figure 18. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type (2019-2024)
Figure 19. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type in 2023
Figure 20. Market Size Share of Cell and Gene Therapy Manufacturing Services by Type (2019-2024)
Figure 21. Market Size Market Share of Cell and Gene Therapy Manufacturing Services by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell and Gene Therapy Manufacturing Services Market Share by Application
Figure 24. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2019-2024)
Figure 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application in 2023
Figure 26. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2019-2024)
Figure 27. Global Cell and Gene Therapy Manufacturing Services Market Share by Application in 2023
Figure 28. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2019-2024)
Figure 30. North America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell and Gene Therapy Manufacturing Services Sales Market Share by Country in 2023
Figure 32. U.S. Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell and Gene Therapy Manufacturing Services Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell and Gene Therapy Manufacturing Services Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell and Gene Therapy Manufacturing Services Sales Market Share by Country in 2023
Figure 37. Germany Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell and Gene Therapy Manufacturing Services Sales Market Share by Region in 2023
Figure 44. China Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (K Units)
Figure 50. South America Cell and Gene Therapy Manufacturing Services Sales Market Share by Country in 2023
Figure 51. Brazil Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell and Gene Therapy Manufacturing Services Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell and Gene Therapy Manufacturing Services Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell and Gene Therapy Manufacturing Services Sales Forecast by Application (2025-2030)
Figure 66. Global Cell and Gene Therapy Manufacturing Services Market Share Forecast by Application (2025-2030)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount